EVOFEM BIOSCIENCES, INC.
12400 High Bluff Drive, Suite 600
San Diego, CA 92130
August 3, 2021
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Mr. Jason Drory
Re: Evofem Biosciences, Inc.
Registration Statement on Form S-3
Filed July 30, 2021
File No. 333- 258321 (the “Registration Statement”)
Acceleration Request
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, Evofem Biosciences, Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement to Thursday, August 5, 2021, at 4:01 p.m., Eastern Time, or as soon as thereafter practicable.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Please contact Melanie Levy of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (858) 314-1873 with any questions regarding this request.
Very truly yours, | |||||
EVOFEM BIOSCIENCES, INC. | |||||
/s/ Justin J. File | |||||
Justin J. File Chief Financial Officer |
cc: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Melanie Levy, Esq.
Sebastian Bacon, Esq.